Two Sigma Investments LP Sells 34,643 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)

Two Sigma Investments LP reduced its position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 9.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 317,856 shares of the medical instruments supplier's stock after selling 34,643 shares during the quarter. Two Sigma Investments LP owned about 0.79% of AngioDynamics worth $2,912,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Systematic Financial Management LP grew its holdings in shares of AngioDynamics by 4.6% during the 4th quarter. Systematic Financial Management LP now owns 2,521,065 shares of the medical instruments supplier's stock valued at $23,093,000 after purchasing an additional 110,719 shares during the last quarter. Polar Asset Management Partners Inc. bought a new stake in shares of AngioDynamics during the 4th quarter valued at approximately $1,697,000. ProShare Advisors LLC bought a new stake in shares of AngioDynamics during the 4th quarter valued at approximately $100,000. Nuveen Asset Management LLC grew its holdings in shares of AngioDynamics by 37.4% during the 4th quarter. Nuveen Asset Management LLC now owns 1,296,366 shares of the medical instruments supplier's stock valued at $11,875,000 after purchasing an additional 353,070 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of AngioDynamics by 4.6% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,968 shares of the medical instruments supplier's stock valued at $201,000 after purchasing an additional 969 shares during the last quarter. 89.43% of the stock is owned by institutional investors.

AngioDynamics Stock Performance

Shares of AngioDynamics stock traded up $0.01 during midday trading on Wednesday, hitting $10.96. 488,663 shares of the company traded hands, compared to its average volume of 570,763. The stock has a market cap of $445.05 million, a price-to-earnings ratio of -1.95 and a beta of 0.58. The firm's fifty day moving average price is $9.49 and its 200-day moving average price is $9.64. AngioDynamics, Inc. has a 12 month low of $5.47 and a 12 month high of $13.50.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last posted its earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.16. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The firm had revenue of $72.00 million for the quarter, compared to analyst estimates of $70.30 million. The firm's revenue was down 4.3% compared to the same quarter last year. Equities research analysts forecast that AngioDynamics, Inc. will post -0.37 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a "buy" rating and set a $16.00 price target (up from $15.00) on shares of AngioDynamics in a report on Monday, April 7th.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.